Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe

被引:166
作者
Koletzko, S.
Richy, F.
Bontems, P.
Crone, J.
Kalach, N.
Monteiro, M. L.
Gottrand, F.
Celinska-Cedro, D.
Roma-Giannikou, E.
Orderda, G.
Kolacek, S.
Urruzuno, P.
Martinez-Gomez, M. J.
Casswall, T.
Ashorn, M.
Bodanszky, H.
Megraud, F.
机构
[1] Univ Munich, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany
[2] Univ Bordeaux 2, INSERM, ERI 10, F-33076 Bordeaux, France
[3] Queen Fabiola Childrens Hosp, Brussels, Belgium
[4] Univ Vienna, A-1010 Vienna, Austria
[5] Hop Cochin, F-75674 Paris, France
[6] Inst Nacl Saude Dr Ricardo, Lisbon, Portugal
[7] Hop J Flandre, Lille, France
[8] Childrens Inst, Warsaw, Poland
[9] Univ Athens, Dept Paediat 1, Athens, Greece
[10] Univ Piemonte Orientale, Novara, Italy
[11] Univ Zagreb, Childrens Hosp, Zagreb, Croatia
[12] Hosp 12 Octubre, E-28041 Madrid, Spain
[13] Hosp Nino Jesus, Madrid, Spain
[14] Karolinska Univ Hosp, Stockholm, Sweden
[15] Univ Tampere, FIN-33101 Tampere, Finland
[16] Semmelweis Univ, H-1085 Budapest, Hungary
关键词
D O I
10.1136/gut.2006.091272
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim: To prospectively assess the antibacterial resistance rate in Helicobacter pylori strains obtained from symptomatic children in Europe. Methods: During a 4-year period, 17 paediatric centres from 14 European countries reported prospectively on patients infected with H pylori, for whom antibiotic susceptibility was tested. Results: A total of 1233 patients were reported from Northern (3%), Western (70%), Eastern (9%) and Southern Europe (18%); 41% originated from outside Europe as indicated by mother's birth-country; 13% were,6 years of age, 43% 6 - 11 years of age and 44% > 11 years of age. Testing was carried out before the first treatment (group A, n = 1037), and after treatment failure (group B, n = 196). Overall resistance to clarithromycin was detected in 24% (mean, A: 20%, B: 42%). The primary clarithromycin resistance rate was higher in boys (odds ratio (OR) 1.58; 1.12 to 2.24, p = 0.01), in children,6 years compared with > 12 years (OR 1.82, 1.10 to 3.03, p = 0.020) and in patients living in Southern Europe compared with those living in Northern Europe (OR 2.25; 1.52 to 3.30, p < 0.001). Overall resistance rate to metronidazole was 25% (A: 23%, B: 35%) and higher in children born outside Europe (A: adjusted. OR 2.42, 95% CI: 1.61 to 3.66, p < 0.001). Resistance to both antibiotics occurred in 6.9% (A: 5.3%, B: 15.3%). Resistance to amoxicillin was exceptional (0.6%). Children with peptic ulcer disease (80/1180, 6.8%) were older than patients without ulcer (p = 0.001). Conclusion: The primary resistance rate of H pylori strains obtained from unselected children in Europe is high. The use of antibiotics for other indications seems to be the major risk factor for development of primary resistance.
引用
收藏
页码:1711 / 1716
页数:6
相关论文
共 25 条
  • [11] An update on anti-Helicobacter pylori treatment in children
    Khurana, R
    Fischbach, L
    Chiba, N
    van Zanten, SV
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 19 (07): : 441 - 445
  • [12] Evaluation of a novel monoclonal enzyme immunoassay for detection of Helicobacter pylori antigen in stool from children
    Koletzko, S
    Konstantopoulos, N
    Bosman, D
    Feydt-Schmidt, A
    van der Ende, A
    Kalach, N
    Raymond, J
    Rüssmann, H
    [J]. GUT, 2003, 52 (06) : 804 - 806
  • [13] Metronidazole resistance and virulence factors in Helicobacter pylori as markers for treatment failure in a paediatric population
    López-Brea, M
    Martínez, MJ
    Domingo, D
    Sánchez, I
    Alarcón, T
    [J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1999, 24 (02): : 183 - 188
  • [14] The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections
    McMahon, BJ
    Hennessy, TW
    Bensler, JM
    Bruden, DL
    Parkinson, AJ
    Morris, JM
    Reasonover, AL
    Hurlburt, DA
    Bruce, MG
    Sacco, F
    Butler, JC
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 139 (06) : 463 - 469
  • [15] Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial:: the MACH 2 study
    Mégraud, F
    Lehn, N
    Lind, T
    Bayerdörffer, E
    O'Morain, C
    Spiller, R
    Unge, P
    Van Zanten, SV
    Wrangstadh, M
    Burman, CF
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) : 2747 - 2752
  • [16] Comparison of non-invasive tests to detect Helicobacter pylori infection in children and adolescents:: Results of a multicenter European study
    Mégraud, F
    [J]. JOURNAL OF PEDIATRICS, 2005, 146 (02) : 198 - 203
  • [17] Basis for the management of drug-resistant Helicobacter pylori infection
    Mégraud, F
    [J]. DRUGS, 2004, 64 (17) : 1893 - 1904
  • [18] Review article:: the treatment of refractory Helicobacter pylori infection
    Mégraud, F
    Lamouliatte, H
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (11) : 1333 - 1343
  • [19] Resistance of Helicobacter pylori to antibiotics and its impact on treatment options
    Mégraud, F
    [J]. DRUG RESISTANCE UPDATES, 2001, 4 (03) : 178 - 186
  • [20] PETERSON WL, 1993, AM J GASTROENTEROL, V88, P1860